They found one cluster comprised participants who tended to die younger, had a higher rate of FTLD-TDP pathological designation, more symptoms of PPA and bvFTD, and lower ADNC burden, while other clusters involved participants who died older, less often with FTD diagnosis, and generally less widespread TDP-43. This evidence concerns the gene TARDBP and frontotemporal dementia.